Standard BioTools Inc. (LAB)

USD 1.99

(-10.18%)

Long Term Debt Summary of Standard BioTools Inc.

  • Standard BioTools Inc.'s latest annual long term debt in 2023 was 3.98 Million USD , down -95.89% from previous year.
  • Standard BioTools Inc.'s latest quarterly long term debt in 2024 Q2 was 299 Thousand USD , down 0.0% from previous quarter.
  • Standard BioTools Inc. reported annual long term debt of 96.89 Million USD in 2022, down -4.78% from previous year.
  • Standard BioTools Inc. reported annual long term debt of 101.75 Million USD in 2021, up 10.12% from previous year.
  • Standard BioTools Inc. reported quarterly long term debt of 28.43 Million USD for 2024 Q3, down 0.0% from previous quarter.
  • Standard BioTools Inc. reported quarterly long term debt of 299 Thousand USD for 2024 Q1, down -92.49% from previous quarter.

Annual Long Term Debt Chart of Standard BioTools Inc. (2023 - 2001)

Historical Annual Long Term Debt of Standard BioTools Inc. (2023 - 2001)

Year Long Term Debt Long Term Debt Growth
2023 3.98 Million USD -95.89%
2022 96.89 Million USD -4.78%
2021 101.75 Million USD 10.12%
2020 92.4 Million USD 58.92%
2019 58.14 Million USD -66.21%
2018 172.05 Million USD -11.87%
2017 195.23 Million USD 0.15%
2016 194.95 Million USD -0.37%
2015 195.68 Million USD 0.12%
2014 195.45 Million USD 0.0%
2013 - USD 0.0%
2012 - USD -100.0%
2011 1.21 Million USD -88.0%
2010 10.13 Million USD -29.89%
2009 14.46 Million USD 2.0%
2008 14.17 Million USD 34.71%
2007 10.52 Million USD -53.08%
2006 22.43 Million USD 0.0%
2001 - USD 0.0%

Peer Long Term Debt Comparison of Standard BioTools Inc.

Name Long Term Debt Long Term Debt Difference
Bionano Genomics, Inc. 7.17 Million USD 44.488%
Prenetics Global Limited 867.21 Thousand USD -359.286%
Star Equity Holdings, Inc. 1.14 Million USD -247.86%
CareDx, Inc 28.27 Million USD 85.915%
Exact Sciences Corporation 2.47 Billion USD 99.839%
Exagen Inc. 19.23 Million USD 79.289%
Inotiv, Inc. 399.4 Million USD 99.003%
Guardant Health, Inc. 1.13 Billion USD 99.651%
Biodesix, Inc. 35.22 Million USD 88.693%
BioNexus Gene Lab Corp. 98.76 Thousand USD -3932.887%
Precipio, Inc. 106 Thousand USD -3657.547%
iSpecimen Inc. 29.13 Thousand USD -13573.189%
Natera, Inc. 282.94 Million USD 98.592%
Aspira Women's Health Inc. 1.43 Million USD -178.531%
23andMe Holding Co. 67.84 Million USD 94.129%
Castle Biosciences, Inc. 14.19 Million USD 71.947%
Personalis, Inc. 1.23 Million USD -222.771%
Aclaris Therapeutics, Inc. 3.07 Million USD -29.571%
Applied DNA Sciences, Inc. 739.16 Thousand USD -438.853%
OpGen, Inc. 2.02 Million USD -97.021%
T2 Biosystems, Inc. 6.59 Million USD 39.633%
Myriad Genetics, Inc. 130.9 Million USD 96.957%
ICON Public Limited Company 3.66 Billion USD 99.891%
NeoGenomics, Inc. 606.06 Million USD 99.343%
Star Equity Holdings, Inc. 1.14 Million USD -247.86%
IDEXX Laboratories, Inc. 622.88 Million USD 99.361%
RadNet, Inc. 812.06 Million USD 99.51%
MDxHealth SA 35.56 Million USD 88.8%
Psychemedics Corporation 945 Thousand USD -321.481%
Illumina, Inc. 1.48 Billion USD 99.733%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 94.969%
DarioHealth Corp. 24.59 Million USD 83.803%
Fulgent Genetics, Inc. 10.11 Million USD 60.607%
Sera Prognostics, Inc. 840 Thousand USD -374.167%
ENDRA Life Sciences Inc. 192.06 Thousand USD -1973.809%
OPKO Health, Inc. 222.03 Million USD 98.206%
Medpace Holdings, Inc. 142.12 Million USD 97.197%
Neogen Corporation 888.39 Million USD 99.552%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -4797.693%
Prenetics Global Limited 867.21 Thousand USD -359.286%
Mainz Biomed B.V. 2.19 Million USD -81.384%
bioAffinity Technologies, Inc. 1.11 Million USD -256.112%
Trinity Biotech plc 54.65 Million USD 92.712%
Neuronetics, Inc. 59.28 Million USD 93.281%
Sotera Health Company 2.22 Billion USD 99.821%
bioAffinity Technologies, Inc. 1.11 Million USD -256.112%